SCHEMBL19786669

SCHEMBL19786669

c1ccc(-n2c3c4ccccc4ccc3c3c4c5ccccc5n(-c5cc(-c6cccnc6)cc(-c6ccccn6)c5)c4c4ccccc4c32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.39
CYP2A6 P11509 2/20 0.39
PIM1 P11309 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
MAPT P10636 2/20 0.34
MCL1 Q07820 1/20 0.33
CYP19A1 P11511 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
CYP11B1 P15538 2/20 0.33
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP17A1 P05093 1/20 0.33
CYP11B2 P19099 1/20 0.33
KDM4E B2RXH2 2/20 0.32
CYP1A1 P04798 1/20 0.32
CYP1A2 P05177 1/20 0.32
PRKDC P78527 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19786304 0.83 MCL1 (0.36) MCL1TP53SMN1; SMN2KDM4ECYP1A1
SCHEMBL15073910 0.81 MAPT (0.41) MAPTCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL19786521 0.81 ALOX12 (0.41) MAPTRAB9AKDM4ECYP1A2L3MBTL1
SCHEMBL15073692 0.80 L3MBTL1 (0.44) GRM5CYP2A6MAPTCYP19A1NPC1
SCHEMBL19651074 0.80 CYP2A6 (0.41) GRM5CYP2A6PIM1PIM2MCL1
SCHEMBL17990542 0.80 CYP2A6 (0.38) GRM5CYP2A6PIM1PIM2MAPT
SCHEMBL17990552 0.79 CYP19A1 (0.38) GRM5CYP2A6PIM1PIM2MAPT
SCHEMBL23733372 0.79 MCL1 (0.41) GRM5MCL1KDM4EL3MBTL1
SCHEMBL19786355 0.78 KDM4E (0.35) GRM5MAPTMCL1NPC1TP53
SCHEMBL19726505 0.77 MCL1 (0.39) GRM5MCL1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-10-03 US disclosed
WO-2018012781-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, OR51E2, ORAI2 GRM5 3044/4885CYP2A6 2721/4885PIM1 1060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.